BIOBANK1 Apr 2021 16:47
I've been a shareholder for about a year and really appreciate the amount of information and research that many members provide through their own hard work and knowledge.
Being a volunteer in the BIOBANK project, I carried out a coronavirus self test for their antibody study today, and submitted the result to them online (positive result, probably as a result of my 1st jab 7 weeks ago).
Although Avacta is antigen technology, I wondered whether there might be a connection as the kit is supplied by Abingdon Health, and incorporates a lateral flow test using a liquid substance to activate the blood sample. The result time is 20 minutes.
Also I am a Techinvest subscriber which as many people will know gives guidance 0n Technology Growth Shares. (In a different league to Motley Fool).
Over the past year or so it has provided coverage on several Covid Stocks such as Open Orphan and Batm. As far as I know they have never covered Avacta which I find puzzling and a lost opportunity to boost the newsletter's credibility.